StockNews.com downgraded shares of Novo Nordisk A/S (NYSE:NVO – Free Report) from a strong-buy rating to a buy rating in a ...

Last month, the U.S. Food and Drug Administration (the “FDA”) announced in a Declaratory Order the resolution of the shortage of semaglutide ...

ASX health stocks broke their losing streak this week, while it was a big week for Nanosonics, Neurizon and Sigma.

Adults with insulin-treated type 2 diabetes had greater HbA1c reductions and larger improvement in time in range with use of ...

The use of an automated insulin delivery (AID) system reduced A1c and hyperglycemia without increasing hypoglycemia in people ...

The explosion of GLP-1 weight loss drugs is reminiscent of the early days of PD-1 inhibitors, but key market differences ...

Novo Nordisk shares rose Monday as the company said it would present new data on the ability of semaglutide, the active ...

Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy ...

Novo Nordisk is a great pick to buy with the stock near its 52-week low. Vertex Pharmaceuticals is helping patients and ...

Picault’s first goal this season came in his second appearance with an assist from defender Jordi Alba — his second — in the ...

Inter Miami CF will have their undefeated record tested on Sunday as they face Atlanta United, the team that knocked them out of the 2024 MLS Cup Playoffs.

AirSculpt Technologies, Inc. (NASDAQ: AIRS) Q4 2024 Earnings Call Transcript March 14, 2025 AirSculpt Technologies, Inc.